Cargando…

The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer

SIMPLE SUMMARY: Although immune-stimulatory and targeted therapies benefit many patients with metastatic kidney cancer, a sizeable proportion of patients fail to respond. Recent studies in mice demonstrate that nutrient-limiting dietary interventions can improve responses to chemotherapy. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orlandella, Rachael M., Turbitt, William J., Gibson, Justin T., Boi, Shannon K., Li, Peng, Smith, Daniel L., Norian, Lyse A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601245/ https://www.ncbi.nlm.nih.gov/pubmed/33036247 http://dx.doi.org/10.3390/cancers12102872

Ejemplares similares

Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
por: Turbitt, William J., et al.
Publicado: (2021)

Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer
por: Gibson, Justin T., et al.
Publicado: (2020)

Obesity diminishes response to PD-1-based immunotherapies in renal cancer
por: Boi, Shannon K, et al.
Publicado: (2020)

Complete biosynthetic pathway to the antidiabetic drug acarbose
por: Tsunoda, Takeshi, et al.
Publicado: (2022)

Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics
por: Turbitt, William J., et al.
Publicado: (2019)

Checkpoint inhibitors in ovarian cancer: A review of preclinical data
por: Doo, David W., et al.
Publicado: (2019)

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice
por: Strong, Randy, et al.
Publicado: (2022)

Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects
por: Buchta, Claire M., et al.
Publicado: (2017)

Short term treatment with a cocktail of rapamycin, acarbose and phenylbutyrate delays aging phenotypes in mice
por: Jiang, Zhou, et al.
Publicado: (2022)

Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?
por: Farag, Kristine I., et al.
Publicado: (2021)

Cap‐independent translation: A shared mechanism for lifespan extension by rapamycin, acarbose, and 17α‐estradiol
por: Shen, Ziqian, et al.
Publicado: (2021)

Physical performance is enhanced in old mice fed a short term diet medicated with rapamycin, acarbose, and phenylbutyrate
por: Ellis, Megan, et al.
Publicado: (2021)

Obesity induces limited changes to systemic and local immune profiles in treatment-naive human clear cell renal cell carcinoma
por: Gibson, Justin T., et al.
Publicado: (2020)

Rapamycin, Acarbose and 17α-estradiol share common mechanisms regulating the MAPK pathways involved in intracellular signaling and inflammation
por: Wink, Lily, et al.
Publicado: (2022)

Acarbose is again on the stage
por: Altay, Mustafa
Publicado: (2022)

The antidiabetic drug acarbose suppresses age-related lesions in C57BL/6 mice in an organ dependent manner
por: Gupta, Sneh, et al.
Publicado: (2021)

Rapid Maturation of Effector T Cells in Tumors, but Not Lymphoid Organs, during Tumor Regression
por: Norian, Lyse A., et al.
Publicado: (2007)

The Anti-Inflammatory Effect of Novel Antidiabetic Agents
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Obesity Triggers Enhanced MDSC Accumulation in Murine Renal Tumors via Elevated Local Production of CCL2
por: Hale, Malika, et al.
Publicado: (2015)

Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose
por: Huang, Jie, et al.
Publicado: (2020)

Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer
por: Norian, Lyse A., et al.
Publicado: (2011)

On the potential of acarbose to reduce cardiovascular disease
por: Standl, Eberhard, et al.
Publicado: (2014)

Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study
por: Chen, Yu-Hsin, et al.
Publicado: (2016)

Piroxicam and Acarbose as Chemopreventive Agents for Spontaneous Intestinal Adenomas in APC Gene 1309 Knockout Mice
por: Quesada, Carlos F., et al.
Publicado: (1998)

Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset
por: Fernandez, Elizabeth, et al.
Publicado: (2019)

Acarbose improved survival for Apc(+/Min) mice
por: Dodds, Sherry G., et al.
Publicado: (2020)

Evaluation of the Bioequivalence of Acarbose in Healthy Chinese People
por: Chen, Yan, et al.
Publicado: (2021)

Preclinical to clinical translation of anti-PD-1 blockade
por: Hirsch, Heather, et al.
Publicado: (2015)

Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients
por: He, Ke, et al.
Publicado: (2014)

Insulin Glargine and Acarbose in the treatment of elderly patients with diabetes
por: Li, Jing, et al.
Publicado: (2019)

Extension of the Life Span by Acarbose: Is It Mediated by the Gut Microbiota?
por: Wu, Baiyun, et al.
Publicado: (2022)

Honey - A Novel Antidiabetic Agent
por: Erejuwa, Omotayo O., et al.
Publicado: (2012)

The effects of antidiabetic agents on heart failure
por: Wijnen, M., et al.
Publicado: (2021)

Anacardium occidentale Bark as an Antidiabetic Agent
por: Encarnação, Sofia, et al.
Publicado: (2022)

Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models
por: Lee, Nancy, et al.
Publicado: (2009)

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
por: Rosak, Christoph, et al.
Publicado: (2012)

Acarbose improves health and lifespan in aging HET3 mice
por: Harrison, David E., et al.
Publicado: (2019)

Method for evaluating the human bioequivalence of acarbose based on pharmacodynamic parameters
por: Xu, Su-Mei, et al.
Publicado: (2020)

A severe leakage of intermediates to shunt products in acarbose biosynthesis
por: Zhao, Qinqin, et al.
Publicado: (2020)

The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment
por: Zhan, Ze-Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_98id53js0gvi3c6hoovgm39rcv